SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Natco Pharma submits copy of transcript of conference call

18 Nov 2016 Evaluate

Natco Pharma has submitted a copy of the transcript of the Conference Call held on November 15, 2016.

The above information is a part of company’s filings submitted to BSE.

Natco Pharma Share Price

890.00 5.65 (0.64%)
23-Jun-2026 15:18 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1867.00
Dr. Reddys Lab 1299.45
Cipla 1430.25
Zydus Lifesciences 1111.55
Lupin 2354.30
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: